India: Intellectual Property

The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".

Relevant trade depends on IP and consumer protection mechanisms to establish equilibrium between business development and customer safeguard practices.

The Indian legal system has two primary means of protecting visual creativity: through the Copyright Act, 1957 and the Designs Act, 2000.

India is witnessing a digital revolution within a techno-commercial environment known as E-Commerce.

Intellectual property laws allow its owners to exclude others from performing certain specified acts, at the same time it allows him to grant third parties special permission to perform any of those acts through licensing, while retaining ownership.

As millions tune into their love for cricket, we log into another IPL: the Indian policy landscape (IPL). This IPL looks more like a test match though, not a T20 — we are all in it for the long haul.

This IP newsletter covers categories of updates relating to Legal Updates, Industry Spotlight, Case Studies and Precedents, Practical Insights for IP Professionals...

Patent revocation is the statutory process of cancelling a granted patent when it does not fulfill the required criteria of intellectual property law.

Indian patent application status refers to the latest status of an application in the tracking system of the Indian Patent Office.

Relevant trade depends on IP and consumer protection mechanisms to establish equilibrium between business development and customer safeguard practices.